Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04740736 · ClinicalTrials.gov registry record · NA
Cardiovascular Analysis of PEM
A NA study of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT04740736: Completed NA study of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis, sponsored by Icahn School of Medicine at Mount Sinai.
NCT04740736 is a NA study of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 106 participants, below the 7,240-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04740736, a NA study of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine cardiopulmonary function in Chronic Fatigue Syndrome (CFS) patients and determine how it relates to the common symptom of Post-exertional malaise (PEM). Subjects will complete a maximal exercise test on 2 subsequent days. Total blood volume will be measured prior to each exercise test, and patient with hypovolemia on day 1, will be randomized to either a saline or sham infusion prior to the 2nd exercise test. A total of 80 CFS patients will be enrolled.
Primary Outcome
To assess VO2VT and peak VO2
Conditions Studied
Interventions
- PROCEDURE Saline Infusion
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2025-07-11 |
| Phase | NA |
What the finished NCT04740736 record still lists
NCT04740736 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 7,240-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Saline Infusion is the first listed.
NCT04740736 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04740736 about?
NCT04740736 is a clinical study titled "Cardiovascular Analysis of PEM". The purpose of this study is to examine cardiopulmonary function in Chronic Fatigue Syndrome (CFS) patients and determine how it relates to the common symptom of Post-exertional malaise (PEM). Subjects will complete a maximal exercise test on 2 subsequent days. Total blood volume will be measured pr...
What is the current status of trial NCT04740736?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2021-08-31. Estimated completion is 2025-07-11.
What conditions does trial NCT04740736 study?
This clinical trial studies the following conditions: Chronic Fatigue Syndrome, Myalgic Encephalomyelitis.
What interventions are being tested in trial NCT04740736?
The interventions under investigation include: Saline Infusion (PROCEDURE).
Who is sponsoring clinical trial NCT04740736?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04740736 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Fatigue Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04740736's enrollment target sits among peer trials
106 5th of 14 higher than 10 of 14 other Chronic Fatigue Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Fatigue Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
RECRUITING · NA
-
tVNS in Long COVID-19
RECRUITING · NA
-
The Long COVID-19 Wearable Device Study
RECRUITING · NA
-
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
ACTIVE NOT RECRUITING · NA
-
Hyporeactivity and Gulf War Illness
COMPLETED · NA
-
Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI